Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats
We evaluated ranirestat, an aldose reductase inhibitor, in diabetic cataract and neuropathy (DN) in spontaneously diabetic Torii (SDT) rats compared with epalrestat, the positive control. Animals were divided into groups and treated once daily with oral ranirestat (0.1, 1.0, 10 mg/kg) or epalrestat...
Saved in:
| Main Authors: | Ayumi Ota, Akihiro Kakehashi, Fumihiko Toyoda, Nozomi Kinoshita, Machiko Shinmura, Hiroko Takano, Hiroto Obata, Takafumi Matsumoto, Junichi Tsuji, Yoh Dobashi, Wilfred Y. Fujimoto, Masanobu Kawakami, Yasunori Kanazawa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2013/175901 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological Features of Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats
by: Yoshiaki Tanaka, et al.
Published: (2019-01-01) -
Repositioning of rhodanine-thiazole hybrids as aldose reductase inhibitors
by: Shankar Gharge, et al.
Published: (2025-09-01) -
Ginsenoside Rb1 alleviates renal tubular epithelial cell injury in diabetic kidney disease by inhibiting the aldose reductase activity
by: Wang Meng-jing, et al.
Published: (2025-07-01) -
Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant Proteins
by: Kirtikar Shukla, et al.
Published: (2017-01-01) -
Computational screening identifies selective aldose reductase inhibitors with strong efficacy and limited off target interactions
by: Jicli Jose Rojas, et al.
Published: (2025-08-01)